Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 1,117 | 1,820 | 2,226 | 2,197 | 5,804 |
| Gross Profit | 1,117 | 1,820 | 2,226 | 2,197 | 5,804 |
| Operating Expenses | 12,432 | 12,554 | 15,327 | 12,959 | 17,251 |
| Operating Income | -11,315 | -10,734 | -13,101 | -10,762 | -11,447 |
| Other Income | 14 | 14 | 15 | 16 | 15 |
| Pre-tax Income | -11,301 | -10,720 | -13,086 | -10,746 | -11,432 |
| Net Income Continuous | -11,301 | -10,720 | -13,086 | -10,746 | -11,432 |
| Net Income | $-11,301 | $-10,720 | $-13,086 | $-10,746 | $-11,432 |
| EPS Basic Total Ops | -0.33 | -0.32 | -0.39 | -0.32 | -0.34 |
| EPS Basic Continuous Ops | -0.33 | -0.32 | -0.39 | -0.32 | -0.34 |
| EPS Diluted Total Ops | -0.33 | -0.32 | -0.39 | -0.30 | -0.34 |
| EPS Diluted Continuous Ops | -0.33 | -0.32 | -0.39 | -0.30 | -0.34 |
| EBITDA(a) | $-11,024 | $-10,434 | $-12,629 | $-10,277 | $-10,927 |